Takeda submits approval request for Novavax’s COVID-19 vaccine in Japan

(Reuters) – Takeda Pharmaceutical Co Ltd has submitted an approval request for Novavax’s COVID-19 vaccine to Japan’s health ministry, the U.S. drugmaker said late on Wednesday.

(Reporting by Shivam Patel in Bengaluru; Editing by Sriraj Kalluvila)